MENU
+Compare
SOLV
Stock ticker: NYSE
AS OF
Aug 20, 10:40 AM (EDT)
Price
$72.21
Change
-$0.06 (-0.08%)
Capitalization
12.53B

SOLV Solventum Corp Forecast, Technical & Fundamental Analysis

Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs... Show more

SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SOLV with price predictions
Aug 19, 2025

SOLV sees MACD Histogram crosses below signal line

SOLV saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 18, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 10 instances where the indicator turned negative. In of the 10 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 15, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SOLV as a result. In of 21 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SOLV moved below its 50-day moving average on August 14, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SOLV entered a downward trend on August 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SOLV advanced for three days, in of 73 cases, the price rose further within the following month. The odds of a continued upward trend are .

SOLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SOLV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.438) is normal, around the industry mean (11.037). P/E Ratio (33.151) is within average values for comparable stocks, (62.634). SOLV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.894). SOLV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (1.505) is also within normal values, averaging (38.690).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SOLV is expected to report earnings to rise 4.73% to $1.77 per share on November 06

Solventum Corp SOLV Stock Earnings Reports
Q3'25
Est.
$1.77
Q2'25
Beat
by $0.01
Q1'25
Missed
by $0.23
Q4'24
Missed
by $0.09
Q3'24
Beat
by $0.10
The last earnings report on August 07 showed earnings per share of $1.69, beating the estimate of $1.68. With 7.22K shares outstanding, the current market capitalization sits at 12.53B.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
3M Center
Phone
+1 651 733-1110
Employees
N/A
Web
https://www.3m.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JETD7.130.08
+1.17%
MAX Airlines -3X Inverse Leveraged ETN
PSF20.42-0.04
-0.20%
COHEN & STEERS SELECT PREFERRED AND Income FUND
AFK21.51-0.26
-1.21%
VanEck Africa ETF
TSYY8.40-0.11
-1.29%
GraniteShares YieldBOOST TSLA ETF
VFMO175.22-3.24
-1.82%
Vanguard US Momentum Factor ETF

SOLV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with NVST. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
+2.13%
NVST - SOLV
48%
Loosely correlated
-0.29%
BAX - SOLV
48%
Loosely correlated
+3.05%
ALC - SOLV
48%
Loosely correlated
+2.26%
AZTA - SOLV
46%
Loosely correlated
-0.43%
RMD - SOLV
45%
Loosely correlated
-0.03%
More

Groups containing SOLV

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
+2.13%
Pharmaceuticals
category (391 stocks)
41%
Loosely correlated
+0.24%
Pharmaceuticals: Other
category (105 stocks)
37%
Loosely correlated
-0.18%